Methylprednisolone vs. dexamethasone in the prevention of postoperative nausea and vomiting: A prospective, randomised, double-blind, placebo-controlled trial

Acta Anaesthesiologica Belgica

Volumn 59, Issue 1, 2008, Pages 1-5

  Weren, Matijn ^a,b   Demeere, Jean Luc ^a  

^a Saint Jean Clinic of Brussels   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Dexamethasone; Methylprednisolone; Postoperative nausea and vomiting

Indexed keywords

ALPRAZOLAM; ATRACURIUM; DESFLURANE; DEXAMETHASONE; KETOROLAC; METHYLPREDNISOLONE; PARACETAMOL; PIRITRAMIDE; PROPOFOL; SUFENTANIL;

ADULT; ANESTHESIA; ANESTHESIA INDUCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; OPTIMAL DRUG DOSE; POSTOPERATIVE ANALGESIA; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RETCHING; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ANTIEMETICS; DEXAMETHASONE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; METHYLPREDNISOLONE; MIDDLE AGED; POSTOPERATIVE NAUSEA AND VOMITING; PROSPECTIVE STUDIES;

EID: 41849151480     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Apfel C. C., et al., A factorial trial of six interventions for the prevention of postoperative nausea and vomiting, NEW ENGLAND JOURNAL OF MEDICINE, 350, 2441-51, 2004.
2. Apfel C. C., Läärä E., Koivuranta M., et al., A simplified risk score for predicting postoperative nausea and vomiting. Conclusions from cross-validations between two centres, ANESTHESIOLOGY, 91, 693-700, 1999.
3. Apfel C. C., Stoecklein K., Lipfert P., PONV : A problem of inhalational anaesthesia ?, BEST PRACT. RES. CLIN. ANAESTH., 19 (3), 485-500, 2005.
4. Baxendale B. R., Vater M., Lavery K. M., Dexamethasone reduces pain and swelling following extraction of third molar teeth, ANESTHESIA, 48, 961-964, 1993.
5. Cohen M. M., Duncan P. G., DeBoer D. P., Tweed W. A., The postoperative interview : assessing risk factors for nausea and vomiting, ANESTH ANALG, 78, 7-16, 1994.
6. Elhakim M., Ali N. M., Rashed I., Riad M. K., Refat M., Dexamethasone reduces postoperative vomiting and pain after pediatric tonsillectomy, CAN. J. ANAESTH., 50 (4), 392-397, 2003.
7. Fillinger M. P., et al., Glucocorticoid effects on the inflammatory and clinical responses to cardiac surgery, J. CARDIOTHORAC. VASC. ANESTH., 16 (2), 163-169, 2002.
8. Fredrikson M., Hursti T., Furst C. J., et al., Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion, BR. J. CANCER, 65, 779-780, 1992.
9. Gan T. J., Postoperative nausea and vomiting - can it be eliminated ?, JAMA, 287 (10), 1233-1236, 2002.
10. Gold B. S., Kitz D. S., Lecky J. H., Neuhaus J. M., Unanticipated admission to the hospital following ambulatory surgery, JAMA, 262, 3008-3010, 1989.
11. Habib A. S., Gan T. J., Evidence-based management of postoperative nausea and vomiting : a review, CAN. J. ANESTH., 51 (4), 326-341, 2004.
12. Harris A. L., Cytotoxic-therapy-induced vomiting is mediated via enkephalin pathways, LANCET, 1, 714-716, 1982.
13. Henzi I., Walder B., Tramer M. R., Dexamethasone for the prevention of postoperative nausea and vomiting : a quantitative systematic review, ANESTH. ANALG., 90, 186-194, 2000.
14. Jordan K., Kasper C., Schmoll H. J., Chemotherapy-induced nausea and vomiting : current and new standards in the antiemetic prophylaxis and treatment, EUR. J. CANCER, 41 (2), 199-205, 2005.
15. Koivuranta M., Laara E., A survey of postoperative nausea and vomiting, ANESTHESIA, 53 (4), 413-414, 1998.
16. Kovac A. L., Prevention and treatment of postoperative nausea and vomiting, DRUGS, 59 (2), 213-243, 2000.
17. Kris M., Gralla R., Tyson L., et al., Controlling delayed vomiting : double-blind randomized trial comparing placebo, alone, and metoclopramide plus dexamethasone in patients receiving cisplatin, J. CLIN. ONCOL., 7, 108-114, 1989.
18. Lee B., Methylprednisolone as an antiemetic, N. ENGL. J. MED., 304, 486-498, 1981
19. Macario A., Weinger M., Carney S., Kim A., Which clinical anesthesia outcomes are important to avoid ? The perspective of patients, ANESTH. ANALG., 89 (3), 652-658, 1999
20. Rich W. M., Abdulhayoglu G., DiSaia P. J., Methylprednisolone as an antiemetic during cancer chemotherapy - a pilot study, GYNECOL. ONCOL., 9, 193-198, 1980.
21. Romundstad L., Breivik H., Roald H., Skolleborg K., Haugen T., Narum J., Stubhaug A., Methylprednisolone reduces pain, emesis, and fatigue after breast augmentation surgery : a single-dose, randomized, parallel-group study with methylprednisolone 125 mg, parecoxib 40 mg, and placebo, ANESTH. ANALG., 102 (2), 418-425, 2006.
22. Sagar S., The current role of anti-emetic drugs in oncology : a recent revolution in patient symptom control, CANCER TREAT. REV., 18 (2), 95-135, 1991.
23. Schumann R., Polaner D. M., Massive subcutaneous emphysema and sudden airway compromise after postoperative vomiting, ANESTH. ANALG., 89, 796-797, 1999.
24. Sinclair D. R., Chung F., Mezei G., Can postoperative nausea and vomiting be predicted ?, ANESTHESIOLOGY, 91, 109-118, 1999.
25. Watcha M. F., Postoperative nausea and emesis, ANESTHESIOL. CLIN. NORTH AM., 20, 709-722, 2002.
26. Young S. N., Mechanism of decline in rat brain 5-hydroxytryptamine after induction of liver tryptophan pyrrolase by hydrocortisone : roles of tryptophan catabolism and kynurenine synthesis, BR. J. PHARMACO, 74 (3), 695-700, 1981.